Bacteriological Quality of Refillable Drinking Water in the Simpang Tiga Area of Samarinda City
Science Publication: Journal of Public Health and Nutrition · 2026
DOI: 10.64965/spjphn.v2i2.56 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Publication: Journal of Public Health and Nutrition, 2026. Verfasst von Anggie Putri Setiawan und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).
Abstract (Originalsprache)
Introduction
Refillable drinking water is widely used because of its accessibility and affordability. However, its bacteriological quality requires monitoring to identify potential microbial contamination.
Objective
To assess the bacteriological quality of refillable drinking water based on total coliform and Escherichia coli parameters in Simpang Tiga, Samarinda City.
Methods
This quantitative descriptive observational study included eight eligible refillable drinking water depots. Samples were examined at the Samarinda City Regional Health Laboratory between November 24 and December 3, 2025, using the three-tube, three-series Most Probable Number (MPN) method. Data were analyzed descriptively.
Results
Seven samples (87.5%) showed total coliform and E. coli results of
Zitieren
APA
Setiawan, A. P., Azahra, S., & Evendi, A. (2026). Bacteriological Quality of Refillable Drinking Water in the Simpang Tiga Area of Samarinda City. Science Publication: Journal of Public Health and Nutrition. https://doi.org/10.64965/spjphn.v2i2.56
Vancouver
Setiawan AP, Azahra S, Evendi A. Bacteriological Quality of Refillable Drinking Water in the Simpang Tiga Area of Samarinda City. Science Publication: Journal of Public Health and Nutrition. 2026. doi:10.64965/spjphn.v2i2.56
BibTeX
@article{Setiawan2026,
author = {Setiawan, Anggie Putri and Azahra, Sresta and Evendi, Agus},
title = {Bacteriological Quality of Refillable Drinking Water in the Simpang Tiga Area of Samarinda City},
journal = {Science Publication: Journal of Public Health and Nutrition},
year = {2026},
doi = {10.64965/spjphn.v2i2.56}
}
EUVIMED